Bedrijfstakpensioenfonds Voor De Media PNO’s Alexion Pharmaceuticals ALXN Stock Holding History

Bedrijfstakpensioenfonds Voor De Media PNO’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-5,800	Closed	-$703K	–	272
2017 Q1	$703K	Hold	5,800	–	–	0.08%	182
2016 Q4	$710K	Hold	5,800	–	–	0.09%	177
2016 Q3	$711K	Hold	5,800	–	–	0.09%	176
2016 Q2	$677K	Hold	5,800	–	–	0.09%	173
2016 Q1	$807K	Sell	5,800 -1,900	-25%	-$279K	0.12%	150
2015 Q4	$1.47M	Hold	7,700	–	–	0.19%	73
2015 Q3	$1.2M	Hold	7,700	–	–	0.16%	126
2015 Q2	$1.39M	Hold	7,700	–	–	0.17%	100
2015 Q1	$1.33M	Buy	+7,700	New	+$1.39M	0.15%	151

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bedrijfstakpensioenfonds Voor De Media PNO's ALXN Position: Q2 2017 in Review

Bedrijfstakpensioenfonds Voor De Media PNO sold out of Alexion Pharmaceuticals (ALXN) in Q2 2017, closing a stake of 5,800 shares — an estimated $703K sold.

Bedrijfstakpensioenfonds Voor De Media PNO first reported a position in ALXN in Q1 2015 and held it in 9 quarters. The position peaked at $1.47M in Q4 2015. 559 funds tracked by Wall St. Rank hold ALXN as of Q2 2017.

Bedrijfstakpensioenfonds Voor De Media PNO reported no remaining Alexion Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Bedrijfstakpensioenfonds Voor De Media PNO sold 5,800 Alexion Pharmaceuticals shares in Q2 2017, an estimated $703K.
Bedrijfstakpensioenfonds Voor De Media PNO first reported a position in Alexion Pharmaceuticals in Q1 2015 and held it in 9 quarters.
Bedrijfstakpensioenfonds Voor De Media PNO's Alexion Pharmaceuticals position peaked at $1.47M in Q4 2015.
559 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2017.

Based on Bedrijfstakpensioenfonds Voor De Media PNO's 13F filing for Q2 2017, filed 19 Jul 2017.